Secondary leukemias and leukemogenesis
Giuseppe Leone, Maria Teresa Voso, Livio Pagano
Biology of Normal and Leukemic Stem Cells
Dominique Bonnet
Epigenetic pathways in hematological malignancies
Santiago Ropero
Therapy-related myeloid leukemia. A model for leukemogenesis
Michelle M. Le Beau, Richard A. Larson
Gene mutations in the pathogenesis of t-MDS
Jens Pedersen-Bjergaard, Mette K. Andersen Morten Tolstrup Andersen ,
Debes H. Christiansen
Ionizing radiation and secondary leukaemia: experimental approaches
Eric G. Wright
The molecular mechanisms of alkylating agent-related acute myeloid leukaemia
James M. Allan
Translocation Mechanism in Secondary Leukemias Following Topoisomerase II
Poisons
Carolyn A. Felix, Blaine W. Robinson, Giuseppe Germano, Christos P. Kolaris,
Leslie J. RaffinI, Luca Lo Nigro, Emily Roumm, Maureen D. Megonigal, Diana J. , Charles Saginario, Brian D. Lovett, Jolanta Libura, Linda D. Pegram, Naiyu Zheng, Shaokun Pang, Xiaoliang Zhou, Eric F. Rappaport, Christine A. Richardson, Nai-Kong V. Cheung, Ian A. Blair
Origin and characteristics of unbalanced chromosome aberrations in therapy-related myelodysplasia and acute myeloid leukemia
Mette K. Andersen, Debes Christiansen, Jens Pedersen-Bjergaard
Defining The Translocation Mechanism In Therapy-Related Acute Promyelocytic Leukaemia
Anita R. Mistry, Ashley Mays, Annabel Mason, Andreas Reiter, Joe Wiemels, Mark Segal, Ellen Solomon, Christine Chomienne, Pierre Fenaux, Carolyn Felix, David Grimwade
Environmental risk factors for MDS/AML
Livio Pagano, Morena Caira, Luana Fianchi, Giuseppe Leone
Detoxification enzyme polymorphisms as risk factors for t-AML
Maria Teresa Voso, Francesco D’Alo’, Giuseppe Leone
Secondary Myeloid Malignancy after Treatment of Acute Lymphoblastic Leukemia (ALL)
Mary V. Relling
Acute leukemia in polycythemia vera
Tiziano Barbui
Secondary myelodysplastic syndrome/acute myeloid leukemia after autologous transplantation
Luca Laurenti, Michela Tarnani, Patrizia Chiusolo, Giuseppe La Torre, Livio Pagano, Gina Zini, Mariagrazia Garzia, Marcella Zollino, Federica Sora’, Simona Sica, Giuseppe Leone
Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 114 adult patients
Rund D, Krichevsky S, Bar-Cohen S, Goldschmidt N, Kedmi M, Malik E, Gural A, Shafran-Tikva S, Ben-Neriah S, Ben-Yehuda D
Should therapy-related myeloid leukemia be treated like de novo acute myeloid leukemia?
Richard A. Larson
Epigenetic targets for treatment in acute myeloid leukemia
Giuseppe Cimino, Francesco Lo Coco, Clara Nervi
Low dose Azanucleosides for high risk (s)MDS and AML
P.W. Wijermans